{
    "nct_id": "NCT04301089",
    "official_title": "A Phase II Feasibility Trial Using Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients",
    "inclusion_criteria": "* INCLUSION CRITERIA:\n* Primary brain tumor (PBT) patients enrolled on the Natural History Study (NHS) trial (16C0151) in the Neuro-Oncology Branch (NOB) who have an upcoming scan and clinical appointment\n* Participants can be newly diagnosed, receiving active treatment, or on surveillance\n* Concurrent enrollment in other NOB trials is permissible\n* Adults (greater than or equal to 18 years of age) who are English-speaking\n* Participants must be able to reliably self-report symptoms, based on clinician assessment\n* Participants report greater than or equal to 1 on distress item from MDASI-BT prior to clinic appointment\n* Active corticosteroid therapy is permissible\n* Ability of subject to understand and the willingness to sign a written informed consent document\n\nEXCLUSION CRITERIA:\n\n* Participants who do not have a tissue diagnosis (no past surgery or biopsy to confirm diagnosis)\n* Cranial surgery less than or equal to 2 weeks prior to initiation of study intervention\n* Scalp wound healing issues that might interfere with comfortable VR headset use\n* Those who have epilepsy or have had a seizure in the last 6 weeks\n* Participants with a current diagnosis of generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), claustrophobia, or panic disorder\n* Participants who have a hypersensitivity to motion or severe nausea, which could make the VR experience uncomfortable\n* Those with visual deficits that might interfere with the VR experience, including hemianopsia, diplopia, and agnosia based on their most recent clinical assessment\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}